City
Epaper

7,700 medicine samples declared poor quality

By IANS | Updated: July 29, 2022 15:45 IST

New Delhi, July 29 A total of 7,700 samples of medicines were declared not of standard quality and ...

Open in App

New Delhi, July 29 A total of 7,700 samples of medicines were declared not of standard quality and 670 declared spurious or adulterated out of a total 84,874 samples picked for testing during the last three years.

The government data disclosed that a total of 2,652 samples of medicines were declared not of standard quality and 263 were declared spurious or adulterated out of a total 84,874 samples picked for testing during the year 2020-21.

The enforcement actions were carried out in terms of samples tested, number of drug samples declared sub-standard and spurious/ adulterated during the last three years. While 164 persons were arrested as the concerned authority initiated prosecutions in the year 2020-21, over 500 such arrests were made in the last three years.

In a reply in the Lok Sabha on Friday, the ministry of Health and Family Welfare said that the manufacture, sale and distribution of drugs in the country are regulated under the provisions of Drugs & Cosmetics Act, 1940 and Rules, 1945. The regulatory control over the manufacture, sale and distribution of drugs in the country is exercised through a system of licensing and inspection by the State Licensing Authorities (SLAs) appointed by respective State Governments. The SLAs are legally empowered to take action in case of violation of the condition of Licence.

The government has taken measures, including strengthening of legal provisions, workshops and training programmes for manufacturers and regulatory officials and measures such as risk based inspection.

In cases of fake and spurious drugs, various enforcement actions like drug seizure, arrests of accused persons / registration of FIR, etc., have been carried out by the states/UTs Drugs Controllers. The Central Drugs Standard Control Organisation (CDSCO) and the Union Ministry of Health and Family Welfare have taken various regulatory measures to ensure the quality of medicines distributed in the country.

The Drugs and Cosmetics Act, 1940 was amended under the Drugs & Cosmetics (Amendment) Act 2008 to provide stringent penalties for manufacture of spurious and adulterated drugs. Certain offences have also been made cognizable and non-bailable. Besides, the states / union territories were requested to set up special courts for trial of offences under the Drugs and Cosmetics Act for speedy disposal. So far, 33 states have already set up designated special courts.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Nationwide Multi-State Licensing System and RegistryNew DelhiMinistry Of Health And Family WelfareSabhaHealth and family welfare ministryMinistry of health and familyMinister for health and family welfareMinistry of health and family welfare ministryThe health and family welfareThe new delhi municipal councilIndian health ministry
Open in App

Related Stories

NationalNew Delhi Railway Station Sees ‘Stampede-Like’ Chaos Due to Train Delays (Watch)

NationalAmit Shah Reviews Delhi’s Law & Order Situation, Says Illegal Intruders Will Be Identified and Deported

NationalDelhi: Speaker Vijendra Gupta Responds To LoP Atishi’s Letter, Says, “Surprising That Opposition Is Not Aware Of Rules”

NationalSupreme Court Dismisses Plea on Delhi Railway Station Stampede, Questions Evidence of 200 Deaths

NationalDelhi Metro Update: DMRC to Operate Special Early Morning Services for New Delhi Marathon 2025 on Feb 23; Check Full Schedule

Health Realted Stories

HealthCentre extends financial aid to indigenous indoor air purification solution

HealthChildhood exposure to bacterial toxin can trigger Colorectal cancer among the young: Study

HealthIndia achieves breakthrough in gene therapy for haemophilia: Minister

LifestyleWalking Tips for Summer: Know the Best time to Walk to Avoid Heatstroke

HealthCentre launches campaign to achieve 100 pc Measles-Rubella immunisation coverage